Related Experiment Video
Updated: Feb 7, 2026

Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin
Published on: March 3, 2021
Exocyclic Sulfur and Selenoorganic Compounds Towards Their Anticancer Effects: Crystallographic and Biological
Ewa Żesławska1, Annamária Kincses2, Vivien Unger2
1Department of Chemistry, Institute of Biology, Pedagogical University of Cracow, Kraków, Poland ewa.zeslawska@up.krakow.pl.
Background/Aim:
Multidrug resistance leads to therapeutic difficulties. There is great interest in experimental chemotherapy regarding multidrug resistance inhibitors and new anticancer agents. The aim of this study was to evaluate the anticancer activity of exocyclic sulfur and selenoorganic compounds on mouse T-lymphoma cell lines.
Materials And Methods:
A series of eighteen sulfur and selenium analogues of 2[1H]-pyrimidinone and hydantoin derivatives were evaluated towards their efflux modulating, cytotoxic and antiproliferative effects in mouse T-lymphoma cells. The combination assay with doxorubicin on multidrug resistant mouse T-lymphoma cells was performed in order to see the nature of drug interactions. Crystal structures were determined for two selected compounds with the highest efflux-modulating activity.
Results:
The sulfur analogues with aromatic rings almost perpendicular to pyrimidinethione ring at positions 1 and 6 showed the highest efflux inhibitory action, while all selenium analogues showed good antiproliferative and cytotoxic activities.
Conclusion:
The sulfur analogues can be modified towards improving their efflux inhibitory activity, whereas the selenium towards antiproliferative and cytotoxic activities.
Insights
New sulfur and selenium compounds show promise as anticancer agents. Sulfur analogues inhibit drug efflux, while selenium compounds exhibit potent cytotoxic and antiproliferative effects against mouse T-lymphoma cells.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Organic Chemistry
Background:
- Multidrug resistance (MDR) presents significant challenges in cancer chemotherapy.
- Developing novel anticancer agents and MDR inhibitors is crucial for improving treatment outcomes.
Purpose of the Study:
- To evaluate the anticancer potential of novel exocyclic sulfur and selenoorganic compounds.
- To assess their activity against mouse T-lymphoma cell lines, focusing on drug efflux modulation, cytotoxicity, and antiproliferative effects.
Main Methods:
- Synthesis and evaluation of eighteen sulfur and selenium analogues of 2[1H]-pyrimidinone and hydantoin derivatives.
- Assays for efflux modulation, cytotoxicity, and antiproliferation in mouse T-lymphoma cells.
- Combination studies with doxorubicin on multidrug-resistant cells and crystal structure determination of key compounds.
Main Results:
- Sulfur analogues with specific aromatic ring orientations demonstrated significant efflux inhibitory activity.
- Selenium analogues exhibited notable antiproliferative and cytotoxic effects.
- Two compounds with the highest efflux-modulating activity had their crystal structures determined.
Conclusions:
- Sulfur analogues offer a scaffold for developing improved efflux inhibitors.
- Selenium analogues show potential for enhancement in antiproliferative and cytotoxic activities.
- These compounds represent promising leads for novel anticancer drug development.
Related Concept Videos
Biological Effects of Radiation
The Sulfur Cycle
Sulfur Assimilation
Molecules and Compounds
Organic Compounds
Classification of Elements and Compounds
Compounds are pure substances composed of two or more elements in fixed, definite proportions. Compounds are classified as ionic or molecular (covalent) based on the bonds...

